cgmp fda No Further a Mystery
No. 21 CFR 211.113(a) requires correct published procedures being established and adopted for the duration of manufacturing to circumvent objectionable microorganisms in drug items not required to be sterile. Additionally, the 2nd paragraph of USP Common Chapter Antimicrobial Usefulness Screening reads: Antimicrobial preservatives really s